These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2939362

  • 21. Dopamine receptors in canine caudate nucleus.
    Maeno H.
    Mol Cell Biochem; 1982 Mar 19; 43(2):65-80. PubMed ID: 6123940
    [Abstract] [Full Text] [Related]

  • 22. Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model.
    Lisovoski F, Haby C, Borrelli E, Schleef C, Revel MO, Hindelang C, Zwiller J.
    Brain Res Bull; 1992 May 19; 28(5):697-701. PubMed ID: 1535533
    [Abstract] [Full Text] [Related]

  • 23. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K, Unemi N, Segawa T.
    Arch Int Pharmacodyn Ther; 1985 Mar 19; 274(1):111-24. PubMed ID: 3925907
    [Abstract] [Full Text] [Related]

  • 24. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C, Ogren SO, Haglund L, Angeby T.
    Neurosci Lett; 1979 Jun 19; 13(1):51-6. PubMed ID: 572522
    [Abstract] [Full Text] [Related]

  • 25. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB, Luttinger D, Hernandez DE, Mailman RB, Mason GA, Davis SD, Widerlöv E, Frye GD, Kilts CA, Beaumont K, Breese GR, Prange AJ.
    J Pharmacol Exp Ther; 1983 May 19; 225(2):337-45. PubMed ID: 6682440
    [Abstract] [Full Text] [Related]

  • 26. Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brain.
    Hall H, Sällemark M.
    Pharmacol Toxicol; 1987 May 19; 60(5):359-63. PubMed ID: 2886988
    [Abstract] [Full Text] [Related]

  • 27. Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the rat.
    Ståhle L, Ljungberg T, Rodebjer A, Ogren SO, Ungerstedt U.
    Pharmacol Toxicol; 1987 Mar 19; 60(3):227-32. PubMed ID: 2884654
    [Abstract] [Full Text] [Related]

  • 28. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T, de Paulis T, Johansson L, Kumar Y, Hall H, Ogren SO.
    J Med Chem; 1990 Aug 19; 33(8):2305-9. PubMed ID: 1973734
    [Abstract] [Full Text] [Related]

  • 29. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan 19; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 30. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM.
    Eur J Pharmacol; 1980 Jun 13; 64(2-3):123-32. PubMed ID: 6105080
    [Abstract] [Full Text] [Related]

  • 31. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG, Roth RH.
    Brain Res; 1981 Feb 02; 205(2):313-9. PubMed ID: 7470869
    [Abstract] [Full Text] [Related]

  • 32. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH, Korf J.
    Eur J Pharmacol; 1976 Nov 02; 40(1):131-6. PubMed ID: 991922
    [Abstract] [Full Text] [Related]

  • 33. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms.
    Jenner P, Clow A, Reavill C, Theodorou A, Marsden CD.
    J Pharm Pharmacol; 1980 Jan 02; 32(1):39-44. PubMed ID: 6102125
    [No Abstract] [Full Text] [Related]

  • 34. Behavioral and biochemical effects of intranigral injection of phospholipase-A2.
    Cadet JL, Hu M, Jackson-Lewis V.
    Biol Psychiatry; 1989 May 02; 26(1):106-10. PubMed ID: 2720020
    [No Abstract] [Full Text] [Related]

  • 35. Behavioral demonstration of a reciprocal interaction between dopamine receptor subtypes in the mouse striatum: possible involvement of the striato-nigral pathway.
    Mandel RJ, Yurek DM, Randall PK.
    Brain Res Bull; 1990 Aug 02; 25(2):285-92. PubMed ID: 2146002
    [Abstract] [Full Text] [Related]

  • 36. Pharmacology of fluperlapine compared with clozapine.
    Eichenberger E.
    Arzneimittelforschung; 1984 Aug 02; 34(1A):110-3. PubMed ID: 6145425
    [Abstract] [Full Text] [Related]

  • 37. Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol.
    Lévesque D, Di Paolo T.
    Neurosci Lett; 1988 May 16; 88(1):113-8. PubMed ID: 2969467
    [Abstract] [Full Text] [Related]

  • 38. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J, Coviella IL, Wurtman RJ.
    Neuropharmacology; 1984 Dec 16; 23(12A):1403-6. PubMed ID: 6543245
    [Abstract] [Full Text] [Related]

  • 39. Behavioural and biochemical studies on 6-methylamino-4,5,6,7-tetrahydrobenzothiazole (14.839JL), a new potent dopaminergic agonist.
    Ponzio F, Algeri S, Garattini S, Cioce V, Rusconi L, Sacchetti G, Manuel C, Notelle C, Duvert L, Legeai J.
    Pharmacol Res Commun; 1987 Aug 16; 19(8):555-65. PubMed ID: 3432322
    [Abstract] [Full Text] [Related]

  • 40. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE, Sorg BA, Chapman MA, Kalivas PW.
    Neuropharmacology; 1991 Dec 16; 30(12A):1269-74. PubMed ID: 1686300
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.